Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Broncus Medical (02216.HK) Announces Annual Results for 2023 2024-03-28 22:32
Sirnaomics Announces 2023 Annual Results 2024-03-28 17:09
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain 2024-03-27 05:59
ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis 2024-03-26 21:00
Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033 2024-03-26 09:57
Scivita Medical Expands Collaboration with Boston Scientific 2024-03-26 09:30
BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167 2024-03-26 08:30
Medipledge, a premium post-laser skincare brand, just launched in Australia 2024-03-25 10:09
Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider 2024-03-25 09:51
Veeva Vault EDC Surpasses 1,000 Study Start Milestone 2024-03-25 08:00
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results 2024-03-22 19:00
The Results of Phase II Clinical Study of KN046 Plus Chemotherapy as First-line Treatment for Metastatic NSCLC were Published in Cell Reports Medicine 2024-03-22 18:42
Antengene Announces Full Year 2023 Financial Results, Highlights Clinical Progress Across First-in-Class, Best-in-Class Pipeline 2024-03-22 18:00
NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy 2024-03-22 08:00
Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved 2024-03-21 19:47
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
1 27 28 29 30 31 235